Title
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
Pro-Inflammatory Effects of Two Different Doses of 17 Beta Estradiol in Menopausal Women
Phase
Phase 3Lead Sponsor
University of ParisStudy Type
InterventionalStatus
TerminatedIndication/Condition
Healthy Symptomatic Menopausal WomenIntervention/Treatment
estradiol ...Study Participants
99Primary purpose : Effects of two doses of hormone therapy on hsCRP. The effects of hormone replacement therapy on inflammatory markers are dose-dependent.
Pro-inflammatory study of the effects in short term of two difference doses of 17beta-estradiol at the menopause woman
CLIMASTON(drug)
17 Beta-estradiol (2mg/day)and (1mg/day)
placebo
17 Beta-estradiol (2mg/day)and (1mg/day)
Inclusion Criteria: Symptomatic menopausal women : >=50 years and amenorrhea >=1 year or <50 years and amenorrhea >=1 year and plasmatic FSH >= 30 UI/l Normal mammography in the last 2 years before inclusion Normal cervical smear in the last 2 years before inclusion Written consent for participation in the study Exclusion Criteria: Unconfirmed Menopause with amenorrhoea of less than year Oestrogen-progesterone Treatment anterior in 3 months previous the inclusion Recently a viral Infection or bacteriologic(at least of 2 weeks) Dental Infection Inflammatory Pathology chronicles Antecedent of pathology cancerous with or no a sly hemopathy Addiction to smoking of more than 20 cigarettes a day or an alcoholic consumption furthermore of 4 glasses a day Taken concomitant of one of the treatments forbidden:statine, vitamin B6 or B12, folates, antiinflammatory, anti aggregant Plaquettes, DHEA, phytoestrogens Refusal to sign the assent informed Not membership in a regime about social security